Blood of recovered patients of Covid-19 is to be trialled for treatment
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Sunday
February 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
SUNDAY, FEBRUARY 05, 2023
Blood of recovered patients of Covid-19 is to be trialled for treatment

Health

TBS Report
20 April, 2020, 12:40 pm
Last modified: 20 April, 2020, 04:12 pm

Related News

  • The supply chain crisis opens door to resilience
  • Giving Ukraine jets would need 'months if not years' of training: UK PM
  • 'No magic wand' in Ukraine war, says UK's Wallace on question of supplying jets
  • Hong Kong says 'hello' to woo back visitors after Covid
  • UK economy fares worst among G7 countries in 2023

Blood of recovered patients of Covid-19 is to be trialled for treatment

When a person has Covid-19, their immune system responds by creating antibodies, which attack the virus. Over time these build up and can be found in the plasma, the liquid portion of the blood. The hope is that the antibodies they have built up will help to clear the virus in others

TBS Report
20 April, 2020, 12:40 pm
Last modified: 20 April, 2020, 04:12 pm
 Blood of recovered patients of Covid-19 is to be trialled for treatment

UK is going to use the blood of coronavirus survivors to treat hospital patients ill with the disease.

NHS Blood and Transplant (NHSBT) wants people who recovered from Covid-19 to donate blood so they can potentially assess the therapy in trials, reports BBC.

When a person has Covid-19, their immune system responds by creating antibodies, which attack the virus. Over time these build up and can be found in the plasma, the liquid portion of the blood.

NHSBT is now approaching patients who have recovered from Covid-19 to donate blood for starting the plasma trial. The hope is that the antibodies they have built up will help to clear the virus in others.

A statement from NHSBT said, "We envisage that this will be initially used in trials as a possible treatment for Covid-19."

"All clinical trials have to follow a rigorous approval process to protect patients and to ensure robust results are generated. We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible." it added.

Several groups in the UK have been looking into using blood plasma.

Professor Sir Robert Lechler, president of the Academy of Medical Sciences said, "I would be disappointed if we weren't able to see some patients given this form of therapy within a couple of weeks. Let's hope that the NHSBT national trial gets into gear really quickly."

Meanwhile, the US had already started its plasma trial three weeks ago which has treated 600 patients so far.

Prof Michael Joyner, from the Mayo Clinic, is leading the work.

He said: "The thing we've learned in the first week of administration is that no major safety signals have emerged and administration of the product does not appear to be causing a whole lot of unanticipated side effects."

He said the therapy was "rough and ready".

"There's a lot we don't understand about the plasma. We're going to learn more about what's in the plasma, the components, the antibody levels, and other factors that may be there as the weeks go on. But sometimes, as a physician, you just have to try to take a shot on goal when you have a shot." he added.

 

 

Coronavirus chronicle / Top News

Plasma trial / UK / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • GDP growth drops to 7.1% in FY22, per capita income $2,793
    GDP growth drops to 7.1% in FY22, per capita income $2,793
  • Consumers should pay actual costs to get gas, electricity: PM
    Consumers should pay actual costs to get gas, electricity: PM
  • Dr Debapriya Bhattacharya. Illustration: TBS
    Development won't sustain sans political consensus: Debapriya 

MOST VIEWED

  • Photo: TBS
    All the districts now at risk of Nipah virus: IEDCR
  • Major Nipah outbreak feared as infections hit eight-year high
    Major Nipah outbreak feared as infections hit eight-year high
  • Illustration: TBS
    Woes of cancer care: Scarce treatment facilities keep patients wait for months
  • Photo: TBS
    32 districts at risk of Nipah virus: DGHS
  • Infographic: TBS
    Isolation ward, ICU beds at DNCC Covid Hospital ready for Nipah virus patients 
  • Photo: Collected
    Kidney and cornea donation: Sarah Islam should get state honour posthumously

Related News

  • The supply chain crisis opens door to resilience
  • Giving Ukraine jets would need 'months if not years' of training: UK PM
  • 'No magic wand' in Ukraine war, says UK's Wallace on question of supplying jets
  • Hong Kong says 'hello' to woo back visitors after Covid
  • UK economy fares worst among G7 countries in 2023

Features

Say it with Colours

Say it with Colours

11h | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

13h | Panorama
Google must adjust to a world where content is increasingly generated by AI. Photo: Bloomberg

Google will join the AI wars, pitting LaMDA against ChatGPT

10h | Panorama
The megaproject Rooppur Nuclear Power Plant has a debt of Tk90,474 crore. Photo: Courtesy

Projects funded with debt need to be selected prudently, and implemented timely

11h | Panorama

More Videos from TBS

ICB to withdraw Padma Bank Investment as return

ICB to withdraw Padma Bank Investment as return

4h | TBS Insight
Kiara Advani & Sidharth Malhotra's Wedding Update

Kiara Advani & Sidharth Malhotra's Wedding Update

4h | TBS Entertainment
What you probably didn't know about CR7

What you probably didn't know about CR7

1h | TBS SPORTS
US shoots down Chinese spy balloon

US shoots down Chinese spy balloon

2h | TBS World

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

4
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]